Biomaterials have been in use for long in the human body to improve body functions and replace damaged tissues. These biodegradable biomaterials have evolved from biomaterials that do not react with the environment and easily dissolve in the body. Advances in technology and the emergence of innovative biomaterial products have enhanced the performance and applications of these biomaterials. Metals and ceramics dominate the biomaterials market. The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015.

Biomaterial market holds significant opportunity for innovators; an extensive research is required to develop new and improved products at competitive prices. With increase in the percentage of aging population worldwide, the number of individuals suffering from physical disability is also increasing. Baby boomers born between 1946 and 1964 are the major consumers of the biomaterial products. Besides, more than 20% of the global population in 2050 is expected to be over 60 years and this segment (of the population) will be significantly high in developing countries. This increase in the aging population will drive the demand for biomaterial products.

Biomaterial products are expensive; and an improvement in performance would justify the higher pricing and also boost the market size. The U.S. government is expected to spend more in the medical care sector; which, in turn, could boost the market for biomaterials; provided the economy revives. Technological advancements in the orthopedic and prosthetic applications have increased the demand for surgical appliances that uses biomaterials. With the increase in healthcare spending, the demand for surgical appliances also increases, which indirectly impacts the demand for biomaterials in surgical appliances.

The orthopedic reconstructive market relates to products that can be used as replacement for natural bones and joints. In 2009, the orthopedic reconstructive biomaterial market contributed 31.8% to the global orthopedic biomaterial market. This market is categorized into artificial knee, artificial hip, and other reconstructive products. The artificial knee segment dominated the market with a 50.4% share.

Markets covered

This research report categorizes the biomaterials market into the following:

• Biomaterial market, by products: Orthopedic, cardiovascular, wound care, gastrointestinal, urological, plastic surgery, and others
• Biomaterial market, by materials: Metals, polymers, ceramics, and composites
• Biomaterial market, by application: General surgery, surgical appliances and supplies, surgical and medical instruments, dental products, electro medical equipment and other applications

The report provides market estimates and forecasts for the global biomaterial market. In addition to market sizing and forecasts, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.

Stakeholders

The targeted audience for this report includes:

• Pharmaceutical and biotech companies
• Medical devices manufacturers
• Pharma-research labs
• Doctors, physicians and hospitals
• Medical/Pharma associations
• Retailers and super-retailers
• Technology providers
• Research and development (R&D) companies

Research Methodology

Secondary research is carried out using proprietary databases (both paid and public), company websites, and news articles. The primary research involves interviews with specialists, CEO’s, managers, and directors working with major market players (key industry players), and subject matter experts from research institutes. Data and analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others have been validated with primary research. Market size of the segments was calculated using the bottom-up approach and figures thus derived were added to yield the biomaterial market revenues, while each year’s forecast is based on the analysis of industry trends.

TABLE OF CONTENTS

EXECUTIVE SUMMARY
  MARKET OVERVIEW
 
1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
 
2 SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 DEFINING THE GLOBAL BIOMATERIAL MARKET
  3.3 DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET
      3.3.1 SUPPLY SIDE DRIVERS
      3.3.2 DEMAND SIDE DRIVERS
      3.3.3 RESTRAINTS
      3.3.4 OPPORTUNITIES
      3.3.5 KEY COMPETITIVE POINTS
 3.4 DRIVERS
      3.4.1 NEW & IMPROVED TECHNOLOGIES
      3.4.2 DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE
      3.4.3 LARGE APPLICATION AREA
      3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS
      3.4.5 RISING AWARENESS
      3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS
      3.4.7 BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS
      3.4.8 MEDICAL INSURANCE COVERAGE
      3.4.9 RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH
      3.4.10 INCREASING FOCUS ON PERSONAL HEALTHCARE
 3.5 INHIBITORS
      3.5.1 LACK OF TISSUE AVAILABILITY
      3.5.2 LACK OF PROPER REIMBURSEMENT FACILITIES
 3.6 OPPORTUNITIES
      3.6.1 MARKET PARTICIPATION BY SMALLER COMPANIES
      3.6.2 GROWING NEED FOR INTEGRATED & COMBINED MATERIALS
      3.6.3 INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS
      3.6.4 EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY
 
4 BIOMATERIAL MARKET – BY PRODUCTS
  4.1 INTRODUCTION
  4.2 ORTHOPEDIC BIOMATERIAL
      4.2.1 DRIVERS
            4.2.1.1 Product penetration
            4.2.1.2 Increasing use of orthopedic biomaterials in spine surgery
            4.2.1.3 Easy surgical procedures
      4.2.2 INHIBITORS
            4.2.2.1 Economic constraints
            4.2.2.2 Increasing competition reduces profit margin
      4.2.3 OPPORTUNITIES
            4.2.3.1 Spinal treatment expected to be on the rise
      4.2.4 TOP PLAYER ANALYSIS OF ORTHOPEDIC   BIOMATERIAL MARKET
      4.2.5 ORTHOPEDIC RECONSTRUCTIVE BIOMATERIAL
            4.2.5.1 Drivers
                    4.2.5.1.1 Wide range of products available for specific applications
                    4.2.5.1.2 Development of new materials with improved properties
            4.2.5.2 Inhibitors & opportunities
            4.2.5.3 Top players analysis in orthopedic reconstructive market
            4.2.5.4 Artificial knee
                    4.2.5.4.1 Constraint implants
                    4.2.5.4.2 Non-constraint implants
                    4.2.5.4.3 Semi-constraint implants
            4.2.5.5 Artificial hip
                    4.2.5.5.1 Cemented prostheses biomaterial market
                    4.2.5.5.2 Uncemented prostheses biomaterial market
      4.2.6 ORTHOBIOLOGICS BIOMATERIAL
            4.2.6.1 Top player analysis of orthobiologics biomaterial market
            4.2.6.2 Machined bone allografts
            4.2.6.3 Demineralized bone matrix (DBM)
            4.2.6.4 Bone morphogenic protein (BMP)
            4.2.6.5 Synthetic bone substitute
            4.2.6.6 Non-proprietary allografts
            4.2.6.7 Platelet concentrates
      4.2.7 BONE CEMENT
            4.2.7.1 Drivers
                    4.2.7.1.1 Bone cements ease lesions & can be used with antibiotics
            4.2.7.2 Inhibitors & opportunities
            4.2.7.3 Top player analysis of bone cement orthopedic biomaterial market
      4.2.8 TRAUMA BIOMATERIAL
            4.2.8.1 Drivers
            4.2.8.1.1 Sports injuries & other accidents
            4.2.8.1.2 Plate & screw systems drive overall market growth
            4.2.8.2 Top players analysis of trauma orthopedic biomaterial market
      4.2.9 SPINAL BIOMATERIAL
            4.2.9.1 Drivers
                    4.2.9.1.1 Spinal treatment for younger patients on the rise
                    4.2.9.1.2 Motion - preserving devices drive growth
            4.2.9.2 Inhibitors & Opportunities
                    4.2.9.2.1 Reimbursement challenges restrain growth
                    4.2.9.2.2 Technology & product development provide scope for improvement
            4.2.9.3 Top player analysis of spine orthopedic biomaterial market
            4.2.9.4 Cervical biomaterials
            4.2.9.5 Lumbar biomaterials
      4.2.10 SPORTS MEDICINE
            4.2.10.1 Drivers
            4.2.10.2 Top player analysis of sports medicine orthopedic biomaterial market
      4.2.11 DENTAL ORTHOPEDICS
            4.2.11.1 Drivers
            4.2.11.2 Inhibitors & Opportunities
            4.2.11.3 Top player analysis of dental orthopedic biomaterial market
            4.2.11.4 Dental bone grafts and substitutes
                     4.2.11.4.1 Dental allograft
                     4.2.11.4.2 Dental synthetic
                     4.2.11.4.3 Dental xenograft
            4.2.11.5 Dental membranes
            4.2.11.6 Tissue regeneration
  4.3 CARDIOVASCULAR BIOMATERIAL
      4.3.1 DRIVERS
            4.3.1.1 Biomaterials enhance cardiovascular treatment
            4.3.1.2 Rising number of obesity cases
            4.3.1.3 Increase in thrombosis and heart failure treatments
            4.3.1.4 Vascular surgery market is growing with the use of biomaterials
      4.3.2 INHIBITORS & OPPORTUNITIES
      4.3.3 TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET
      4.3.4 CARDIAC STENTS
            4.3.4.1 Top player analysis of cardiac stents biomaterial market
      4.3.5 PERIPHERAL VASCULAR GRAFTS
      4.3.6 VASCULAR ACCESS DEVICES
            4.3.6.1 Drivers & Inhibitors
            4.3.6.2 Top player analysis of vascular access devices biomaterial market
      4.3.7 CARDIAC PACEMAKER
            4.3.7.1 Top player analysis of cardiac pacemaker cardiovascular biomaterial market
      4.3.8 ARTIFICIAL HEART VALVE
            4.3.8.1 Top player analysis of artificial heart valve cardiovascular biomaterial market
      4.3.9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      4.3.9.1 Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
  4.4 WOUND CARE BIOMATERIAL
      4.4.1 DRIVERS
            4.4.1.1 Multiple advantages over conventional wound care products
            4.4.1.2 Supports healing process of the skin
            4.4.1.3 Gel-based products accelerate wound healing
            4.4.1.4 Prevention of bacterial colonization on sutures
            4.4.1.5 Reduction in the cost of hospitalization
            4.4.1.6 Eliminates frequent change of dressings
            4.4.1.7 Increase in diabetes foot ulcer
      4.4.2 INHIBITORS
            4.4.2.1 Slow rate of product development
      4.4.3 OPPORTUNITIES
            4.4.3.1 Increase in penetration of negative pressure wound
            4.4.3.2 Introduction of more efficient and cost effective therapies
            4.4.3.3 Use of natural polymer biomaterials for stability in treatment
      4.4.4 TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET
      4.4.5 SURGICAL HEMOSTATS
            4.4.5.1 Drivers
                    4.4.5.1.1 Surgical hemostats control bleeding
                    4.4.5.1.2 Reduces need for frequent blood transfusions
            4.4.5.2 Top player analysis of surgical hemostats market
            4.4.5.3 Thrombin-based hemostats
            4.4.5.4 Oxidized regenerated cellulose-based hemostats
            4.4.5.5 Collagen-based hemostats
            4.4.5.6 Autologous-based hemostats
            4.4.5.7 Polysaccharide based hemostats
            4.4.5.8 Gelatin-based hemostats
            4.4.5.9 Combination hemostats
      4.4.6 SKIN SUBSTITUTE
      4.4.7 INTERNAL TISSUE SEALANT
            4.4.7.1 Drivers
                    4.4.7.1.1 Technological advances
                    4.4.7.1.2 Wide range of applications & features
                    4.4.7.1.3 Faster healing
            4.4.7.2 Top player analysis of internal tissue sealant wound care biomaterial market
            4.4.7.3 Fibrin-based sealants
            4.4.7.4 Synthetic-based sealant
      4.4.8 ADHESION BARRIERS
            4.4.8.1 Drivers
            4.4.8.2 Inhibitors & Opportunities
            4.4.8.3 Top player analysis of adhesion prevention wound care biomaterial market
            4.4.8.4 Films
            4.4.8.5 Gels
  4.5 PLASTIC SURGERY BIOMATERIAL
      4.5.1 DRIVERS
            4.5.1.1 Baby boomers to boost market growth
            4.5.1.2 More surgeons are moving towards plastic surgery from reconstructive procedures
            4.5.1.3 Cultural factors boost market growth
      4.5.2 INHIBITORS & OPPORTUNITIES
            4.5.2.1 Difficulties in treating craniofacial trauma
            4.5.2.2 Male population untapped for facial surgeries
      4.5.3 TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET
      4.5.4 FACIAL IMPLANTS
            4.5.4.1 Drivers
                    4.5.4.1.1 Iraq war increased demand for facial implants
                    4.5.4.1.2 Faster recovery
            4.5.4.2 Inhibitors & Opportunities
            4.5.4.3 Top player analysis of facial implants biomaterial market
      4.5.5 INJECTABLE FILLERS
            4.5.5.1 Drivers
                    4.5.5.1.1 Increase in awareness of skin care
                    4.5.5.1.2 Permanent results can be achieved using fillers
            4.5.5.2 Inhibitors & Opportunities
                    4.5.5.2.1 Allergy
            4.5.5.3 Top player analysis of injectable fillers biomaterial market
      4.5.6 BREAST IMPLANTS
            4.5.6.1 Drivers
                    4.5.6.1.1 Availability of more refined procedures
            4.5.6.2 Inhibitors & Opportunities
            4.5.6.3 Top player analysis of breast implants biomaterial market
            4.5.6.4 Silicone gel implants
            4.5.6.5 Saline-filled implants
  4.6 UROLOGICAL BIOMATERIAL
      4.6.1 DRIVERS
            4.6.1.1 Availability of biodegradable materials for treatment
            4.6.1.2 Development of scaffolds for treatment of several disorders
      4.6.2 INHIBITORS & OPPORTUNITIES
      4.6.3 TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET
      4.6.4 STENTS
            4.6.4.1 Drivers
                    4.6.4.1.1 Stents are used in short duration treatment
                    4.6.4.1.2 Growing population
            4.6.4.2 Inhibitors & Opportunities
      4.6.5 CATHETERS
            4.6.5.1 Drivers & Inhibitors
                    4.6.5.1.1 Developments in catheter design increased applicability
                    4.6.5.1.2 Prolonged use of catheters may lead to cancer
            4.6.5.2 Opportunities
                    4.6.5.2.1 Use of biomaterials in catheters eliminates certain disadvantages
                    4.6.5.2.2 Biocompatibility of chemicals can be improved in catheters
            4.6.5.3 Dialysis catheter
                    4.6.5.3.1 Top player analysis of dialysis catheter market
            4.6.5.3.2 Hemodialysis catheter
            4.6.5.3.3 Peritonial catheter
            4.6.5.4 Urinary catheter
  4.7 GASTROINTESTINAL BIOMATERIAL
      4.7.1 DRIVERS
            4.7.1.1 Increasing incidence of gastrointestinal diseases
            4.7.1.2 FDA approval for OTC gastrointestinal drugs
      4.7.2 INHIBITORS & OPPORTUNITIES
      4.7.3 TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET
 
5 BIOMATERIAL MARKET – BY TYPES
  5.1 INTRODUCTION
  5.2 METALS
      5.2.1 DRIVERS
            5.2.1.1 Balancing act of metallic biomaterials
            5.2.1.2 Improved properties of metallic biomaterials
      5.2.2 INHIBITORS
            5.2.2.1 Corrosion may occur in the implant
      5.2.3 OPPORTUNITIES
            5.2.3.1 Improvement in corrosion resistance
            5.2.3.2 Introduction of new alloys
      5.2.4 TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET
      5.2.5 PURE FORM METALS
            5.2.5.1 Titanium
            5.2.5.2 Platinum
            5.2.5.3 Silver
            5.2.5.4 Gold
      5.2.6 ALLOYS
            5.2.6.1 Drivers
                    5.2.6.1.1 Easy availability of ore for biomaterials manufacture
                    5.2.6.1.2 Can be sterilized easily
            5.2.6.2 Inhibitors & Opportunities
            5.2.6.3 Top player analysis of alloy biomaterial market
            5.2.6.4 High carbon cobalt chromium alloy
  5.3 CERAMICS
      5.3.1 TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET
      5.3.2 BIOINERT CERAMICS
            5.3.2.1 Drivers
                    5.3.2.1.1 Compatibility with high-strength applications
                    5.3.2.1.2 High chemical stability
            5.3.2.2 Inhibitors & Opportunities
            5.3.2.3 Alumina
            5.3.2.4 Zirconia ceramic
            5.3.2.5 Other bioinert ceramics market
      5.3.3 BIOACTIVE CERAMICS
            5.3.3.1 Drivers
            5.3.3.1.1 Ceramics aid bone formation
            5.3.3.2 Inhibitors & Opportunities
            5.3.3.3 Bioglass
            5.3.3.4 Other bioactive ceramics market
      5.3.4 BIODEGRADABLE CERAMICS
            5.3.4.1 Hydroxyapetite
            5.3.4.2 Others biodegradable biomaterial market
  5.4 POLYMERS
      5.4.1 DRIVERS
            5.4.1.1 Naturally biodegradable
            5.4.1.2 Compatibility in imaging
      5.4.2 INHIBITORS & OPPORTUNITIES
      5.4.3 TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET
      5.4.4 NATURAL POLYMERS
            5.4.4.1 Drivers
                    5.4.4.1.1 Safe to use
                    5.4.4.1.2 Work at a molecular level
            5.4.4.2 Inhibitors & Opportunities
            5.4.4.3 Collagen-based biomaterials
                    5.4.4.3.1 Drivers
            5.4.4.4 Chitosan
            5.4.4.5 Alginate
            5.4.4.6 Others natural polymers
      5.4.5 SYNTHETIC POLYMER BIOMATERIAL
            5.4.5.1 Hyaluronic acid (HA)
            5.4.5.2 PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
            5.4.5.3 PTFE (polytetrafluoroethylene)
            5.4.5.4 Other synthetic polymers
 
6 BIOMATERIAL MARKET – BY APPLICATIONS
  6.1 INTRODUCTION
  6.2 SURGICAL APPLIANCES & SUPPLIES
      6.2.1 DRIVERS
            6.2.1.1 Advanced materials for surgical appliances
            6.2.1.2 Advances in orthopedic & prosthetic applications
            6.2.1.3 Increased healthcare spending in developed countries
            6.2.1.4 No side effects
            6.2.1.5 Biomaterials accelerate natural phenomena
      6.2.2 MARKET INHIBITORS
            6.2.2.1 Lack of capital investment in R&D
            6.2.2.2 Slow approval process
      6.2.3 OPPORTUNITIES
            6.2.3.1 Increase in export opportunities
            6.2.3.2 Future development of artificial organs
            6.2.3.3 Treatment for sleep disorders
  6.3 SURGICAL & MEDICAL INSTRUMENTS
      6.3.1 DRIVERS
            6.3.1.1 Innovations in surgical instruments
            6.3.1.2 Availability of cheap surgical instruments
      6.3.2 INHIBITORS & OPPORTUNITIES
  6.4 DRUG DELIVERY
      6.4.1 DRIVERS
            6.4.1.1 Enabling properties of biomaterials
            6.4.1.2 Most biomaterials are bio-absorbable
            6.4.1.3 Development of quick & effective methods
      6.4.2 INHIBITORS & OPPORTUNITIES
            6.4.2.1 Adverse side effects from certain biomaterials inhibit growth
            6.4.2.2 Nano biomaterials for controlled drug delivery
  6.5 GENERAL SURGERY
      6.5.1 DRIVERS
            6.5.1.1 Synthetic biomaterials make suturing easier
            6.5.1.2 Biomaterials meet the stringent requirements of surgeons
            6.5.1.3 Biomaterials are used as adhesion prevention materials
      6.5.2 INHIBITORS & OPPORTUNITIES
  6.6 ELECTRO-MEDICAL EQUIPMENT
      6.6.1 DRIVERS
            6.6.1.1 Significant increase in patient-base
            6.6.1.2 Demand for efficient procedures and economies of scale
      6.6.2 INHIBITORS & OPPORTUNITIES
  6.7 DENTAL PRODUCTS
      6.7.1 DRIVERS
            6.7.1.1 Biomaterials have wide range of dental applications
            6.7.1.2 Risk of dental disease is set to increase
            6.7.1.3 Improvement in polymers for dental applications
      6.7.2 INHIBITORS & OPPORTUNITIES
  6.8 OTHER APPLICATIONS
 
7 GEOGRAPHIC ANALYSIS
  7.1 INTRODUCTION
  7.2 U.S.
  7.3 EUROPE
  7.4 ASIA
 
8 COMPANY PROFILES
  8.1 3DM INC.
      8.1.1 OVERVIEW
      8.1.2 PRODUCTS & SERVICES
      8.1.3 STRATEGY
      8.1.4 DEVELOPMENTS
  8.2 ADVANSOURCE BIOMATERIALS CORP
      8.2.1 OVERVIEW
      8.2.2 FINANCIALS
      8.2.3 PRODUCTS & SERVICES
      8.2.4 STRATEGY
      8.2.5 DEVELOPMENTS
  8.3 ALLERGAN INC.
      8.3.1 OVERVIEW
      8.3.2 FINANCIALS
      8.3.3 PRODUCTS & SERVICES
      8.3.4 STRATEGY
      8.3.5 DEVELOPMENTS
  8.4 ALLOSOURCE INC.
      8.4.1 OVERVIEW
      8.4.2 PRODUCTS & SERVICES
      8.4.3 STRATEGY
      8.4.4 DEVELOPMENTS
  8.5 ALPHATEC SPINE INC.
      8.5.1 OVERVIEW
      8.5.2 FINANCIALS
      8.5.3 PRODUCTS & SERVICES
      8.5.4 STRATEGY
      8.5.5 DEVELOPMENTS
  8.6 AMEDICA CORPORATION
      8.6.1 OVERVIEW
      8.6.2 PRODUCTS & SERVICES
      8.6.3 STRATEGY
      8.6.4 DEVELOPMENTS
  8.7 ANGIOTECH PHARMACEUTICALS INC.
      8.7.1 OVERVIEW
      8.7.2 FINANCIALS
      8.7.3 PRODUCTS & SERVICES
      8.7.4 STRATEGY
      8.7.5 DEVELOPMENTS
  8.8 ARTIMPLANT AB
      8.8.1 OVERVIEW
      8.8.2 PRODUCTS & SERVICES
      8.8.3 STRATEGY
      8.8.4 DEVELOPMENTS
  8.9 BAXTER INTERNATIONAL INC.
      8.9.1 OVERVIEW
      8.9.2 FINANCIALS
      8.9.3 PRODUCTS & SERVICES
      8.9.4 STRATEGY
      8.9.5 DEVELOPMENTS
  8.10 BIO SYNTECH CANADA INC.
      8.10.1 OVERVIEW
      8.10.2 PRODUCTS & SERVICES
  8.11 BIOCOMPOSITES LTD.
      8.11.1 OVERVIEW
      8.11.2 PRODUCTS & SERVICES
      8.11.3 STRATEGY
      8.11.4 DEVELOPMENTS
  8.12 BIOMET INC.
      8.12.1 OVERVIEW
      8.12.2 FINANCIALS
      8.12.3 PRODUCTS & SERVICES
      8.12.4 STRATEGY
      8.12.5 DEVELOPMENTS
  8.13 BOSTON SCIENTIFIC CORPORATION
      8.13.1 OVERVIEW
      8.13.2 FINANCIALS
      8.13.3 PRODUCTS & SERVICES
      8.13.4 STRATEGY
      8.13.5 DEVELOPMENTS
  8.14 COLLAGEN MATRIX INC.
      8.14.1 OVERVIEW
      8.14.2 PRODUCTS & SERVICES
      8.14.3 STRATEGY
      8.14.4 DEVELOPMENTS
  8.15 COLLPLANT LTD.
      8.15.1 OVERVIEW
      8.15.2 PRODUCTS & SERVICES
      8.15.3 STRATEGY
      8.15.4 DEVELOPMENTS
  8.16 COVALON TECHNOLOGIES LTD.
      8.16.1 OVERVIEW
      8.16.2 FINANCIALS
      8.16.3 PRODUCTS & SERVICES
      8.16.4 STRATEGY
      8.16.5 DEVELOPMENTS
  8.17 CRYOLIFE INC.
      8.17.1 OVERVIEW
      8.17.2 FINANCIALS
      8.17.3 PRODUCTS & SERVICES
      8.17.4 STRATEGY
      8.17.5 DEVELOPMENTS
  8.18 DEPUY ORTHOPEDICS INC.
      8.18.1 OVERVIEW
      8.18.2 FINANCIALS
      8.18.3 PRODUCTS & SERVICES
      8.18.4 STRATEGY
      8.18.5 DEVELOPMENTS
  8.19 ETEX CORPORATION
      8.19.1 OVERVIEW
      8.19.2 PRODUCTS & SERVICES
  8.20 INTEGRA LIFE SCIENCES HOLDINGS CORP
      8.20.1 OVERVIEW
      8.20.2 FINANCIALS
      8.20.3 PRODUCTS & SERVICES
      8.20.4 STRATEGY
      8.20.5 DEVELOPMENTS
  8.21 INVIBIO LIMITED
      8.21.1 OVERVIEW
      8.21.2 PRODUCTS & SERVICES
      8.21.3 STRATEGY
      8.21.4 DEVELOPMENTS
  8.22 MEDTRONIC INC.
      8.22.1 OVERVIEW
      8.22.2 FINANCIALS
      8.22.3 PRODUCTS & SERVICES
      8.22.4 STRATEGY
      8.22.5 DEVELOPMENTS
  8.23 ORTHOVITA INC.
      8.23.1 OVERVIEW
      8.23.2 FINANCIALS
      8.23.3 PRODUCTS & SERVICES
      8.23.4 STRATEGY
      8.23.5 DEVELOPMENTS
  8.24 RTI BIOLOGICS INC.
      8.24.1 OVERVIEW
      8.24.2 FINANCIALS
      8.24.3 PRODUCTS & SERVICES
      8.24.4 STRATEGY
      8.24.5 DEVELOPMENTS
  8.25 SMITH & NEPHEW PLC
      8.25.1 OVERVIEW
      8.25.2 FINANCIALS
      8.25.3 PRODUCTS & SERVICES
      8.25.4 STRATEGY
      8.25.5 DEVELOPMENTS
  8.26 ST. JUDE MEDICAL INC.
      8.26.1 OVERVIEW
      8.26.2 FINANCIALS
      8.26.3 PRODUCTS & SERVICES
      8.26.4 STRATEGY
      8.26.5 DEVELOPMENTS
  8.27 STRYKER CORPORATION
      8.27.1 OVERVIEW
      8.27.2 FINANCIALS
      8.27.3 PRODUCTS & SERVICES
      8.27.4 STRATEGY
      8.27.5 DEVELOPMENTS
  8.28 SYNTHES INC.
      8.28.1 OVERVIEW
      8.28.2 FINANCIALS
      8.28.3 PRODUCTS & SERVICES
      8.28.4 STRATEGY
      8.28.5 DEVELOPMENTS
  8.29 WRIGHT MEDICAL GROUP, INC.
      8.29.1 OVERVIEW
      8.29.2 FINANCIALS
      8.29.3 PRODUCTS & SERVICES
      8.29.4 STRATEGY
      8.29.5 DEVELOPMENTS
  8.30 ZIMMER HOLDING, INC.
      8.30.1 OVERVIEW
      8.30.2 FINANCIALS
      8.30.3 PRODUCTS & SERVICES
      8.30.4 STRATEGY
      8.30.5 DEVELOPMENTS

APPENDIX
  PRODUCTS
  U.S. PATENTS
  EUROPE PATENTS
  JAPAN PATENTS
  BIOMATERIALS
  U.S. PATENTS
  EUROPE PATENTS
  JAPAN PATENTS

LIST OF TABLES
 
1 GLOBAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
3 ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
4 GLOBAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
5 MAJOR PLAYERS & DEVELOPMENTS
6 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
7 RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
8 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
9 MAJOR PLAYERS & DEVELOPMENTS
10 GLOBAL ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
11 ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
12 CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
13 NON-CONSTRAINT IMPLANT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
14 SEMI-CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
15 GLOBAL ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
16 ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
17 CEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
18 UNCEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
19 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE,  BY PRODUCTS 2008 – 2015 ($MILLION)
20 ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
21 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE,  BY DEVICES 2008 – 2015 ($MILLION)
22 MAJOR PLAYERS & DEVELOPMENTS
23 MACHINE BONE ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
24 DBM ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
25 BMP ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
26 SYNTHETIC BONE SUBSTITUTE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
27 NON-PROPRIETARY ALLOGRAFTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
28 PLATELET CONCENTRATES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
29 BONE CEMENT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
30 MAJOR PLAYERS & DEVELOPMENTS
31 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
32 TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
33 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
34 MAJOR PLAYERS & PRODUCT DEVELOPMENT
35 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
36 SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
37 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
38 MAJOR PLAYERS & DEVELOPMENTS
39 GLOBAL CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
40 CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
41 GLOBAL LUMBAR ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
42 LUMBAR SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
43 SPORTS MEDICINE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
44 MAJOR PLAYERS & DEVELOPMENTS
45 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
46 DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
47 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
48 MAJOR PLAYERS & DEVELOPMENTS
49 GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
50 DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDIC BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY  2008 – 2015 ($MILLION)
51 DENTAL ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
52 DENTAL SYNTHETIC ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
53 DENTAL XENOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
54 DENTAL MEMBRANES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
55 TISSUE REGENERATION ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE,  BY PRODUCTS 2008 – 2015 ($MILLION)
57 CARDIOVASCULAR BIOMATERIAL MARKET REVENUE,  BY GEOGRAPHY 2008 – 2015 ($MILLION)
58 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
59 MAJOR PLAYERS & PRODUCT DEVELOPMENTS
60 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
61 CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
62 MAJOR PLAYERS & PRODUCT DEVELOPMENTS
63 PERIPHERAL VASCULAR GRAFTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
64 GLOBAL VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
65 VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
66 MAJOR PLAYERS & DEVELOPMENTS
67 CARDIAC PACEMAKER CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
68 MAJOR PLAYERS & DEVELOPMENTS
69 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
70 ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
71 MAJOR PLAYERS & DEVELOPMENTS
72 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
73 MAJOR PLAYERS & DEVELOPMENTS
74 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
75 WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
76 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
77 MAJOR PLAYERS & DEVELOPMENTS
78 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
79 SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
80 MAJOR PLAYERS & DEVELOPMENTS
81 THROMBIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
82 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
83 COLLAGEN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
84 AUTOLOGOUS-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
85 POLYSACCHARIDE-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
86 GELATIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
87 COMBINATION-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
88 SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
89 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
90 INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
91 MAJOR PLAYERS & DEVELOPMENTS
92 FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
93 SYNTHETIC-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
94 GLOBAL ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
95 ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
96 MAJOR PLAYERS & DEVELOPMENTS
97 FILMS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
98 GELS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
99 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS 2008 – 2015 ($MILLION)
100 PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
101 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET REVENUE,  BY DEVICES 2008 – 2015 ($MILLION)
102 MAJOR PLAYERS & DEVELOPMENT
103 FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
104 MAJOR PLAYERS & DEVELOPMENTS
105 GLOBAL INJECTABLE FILLERS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
106 MAJOR PLAYERS & DEVELOPMENTS
107 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
108 BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
109 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
110 MAJOR PLAYERS & DEVELOPMENTS
111 SILICONE GEL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
112 SALINE-FILLED IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
113 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
114 UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
115 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)
116 MAJOR PLAYERS & DEVELOPMENTS
117 UROLOGICAL STENTS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
118 GLOBAL UROLOGICAL CATHETERS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
119 UROLOGICAL CATHETERS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
120 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
121 DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY  2008 – 2015 ($MILLION)
122 MAJOR PLAYERS & DEVELOPMENTS
123 EMODIALYSIS UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
124 PERITONEAL CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
125 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
126 URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
127 GASTROINTESTINAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
128 MAJOR PLAYERS & DEVELOPMENTS
129 GLOBAL BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
130 GLOBAL METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
131 MAJOR PLAYERS & DEVELOPMENTS
132 GLOBAL PURE FORM METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
133 GLOBAL ALLOY BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
134 MAJOR PLAYERS & DEVELOPMENTS
135 GLOBAL CERAMICS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
136 MAJOR PLAYERS & DEVELOPMENT
137 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS
138 GLOBAL BIOINERT CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
139 GLOBAL BIOACTIVE CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
140 GLOBAL BIODEGRADABLE CERAMICS MARKET REVENUE, BY TYPES  2008 – 2015 ($MILLION)
141 GLOBAL POLYMER BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
142 MAJOR PLAYERS & DEVELOPMENTS
143 GLOBAL NATURAL POLYMERS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)
145 GLOBAL BIOMATERIAL APPLICATIONS MARKET REVENUE, BY TYPES  2008 – 2015 ($MILLION)
146 BIOMATERIAL PRODUCTS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)
147 U.S. BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
148 EUROPE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
149 ASIA BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)
150 ADVANSOURCE BIOMATERIAL REVENUES AND R&D EXPENSES ($MILLION)
151 ADVANSOURCE BIOMATERIAL REVENUES, BY SEGMENTS ($MILLION)
152 ALLERGAN REVENUES AND R&D EXPENSES ($MILLION)
153 ALLERGAN REVENUES, BY SEGMENT ($MILLION)
154 ALLERGAN MEDICAL DEVICES REVENUES, BY SEGMENTS ($MILLION)
155 ALLERGAN REVENUES, BY GEOGRAPHY ($MILLION)
156 ALPHATEC SPINE REVENUES AND R&D EXPENSES ($MILLION)
157 APLHATEC SPINE REVENUES, BY GEOGRAPHY ($MILLION)
158 ANGIOTECH REVENUES AND R&D EXPENSES ($MILLION)
159 ANGIOTECH REVENUES, BY GEOGRAPHY ($MILLION)
160 BAXTER SALES, BY SEGMENTS ($MILLION)
161 BAXTER SALES, BY GEOGRAPHY ($MILLION)
162 BIOMET REVENUES AND R&D EXPENSES ($MILLION)
163 BIOMET REVENUES, BY SEGMENTS ($MILLION)
164 BOSTON SCIENTIFIC REVENUES AND R&D EXPENSES ($MILLION)
165 BOSTON SCIENTIFIC REVENUES, BY GEOGRAPHY ($MILLION)
166 COVALON REVENUES AND R&D EXPENSES ($’000)
167 COVALON REVENUES, BY SEGMENTS ($’000)
168 CRYOLIFE REVENUES AND R&D EXPENSES ($’000)
169 CRYOLIFE REVENUES, BY SEGMENTS ($’000)
170 DEPUY SALES ($BILLION)
171 INTEGRA REVENUES AND R&D EXPENSES ($MILLION)
172 INTEGRA REVENUES, BY GEOGRAPHY ($MILLION)
173 INTEGRA REVENUES, BY SEGMENTS ($MILLION)
174 MEDTRONIC REVENUES AND R&D EXPENSES ($MILLION)
175 MEDTRONIC REVENUES, BY SEGMENTS ($MILLION)
176 ORTHOVITA REVENUES AND R&D EXPENSES ($’000)
177 ORTHOVITA REVENUES, BY GEOGRAPHY ($’000)
178 ORTHOVITA REVENUES, BY SEGMENTS ($’000)
179 RTI BIOLOGICS REVENUES AND R&D EXPENSES ($’000)
180 RTI BIOLOGICS REVENUES, BY SEGMENT (‘000)
181 SMITH & NEPHEW REVENUES AND R&D EXPENSES ($MILLION)
182 SMITH & NEPHEW REVENUES, BY GEOGRAPHY ($MILLION)
183 SMITH & NEPHEW REVENUE, BY SEGMENTS ($MILLION)
184 ST. JUDE SALES AND R&D EXPENSES ($MILLION)
185 ST. JUDE SALES, BY SEGMENTS ($MILLION)
186 ST. JUDE SALES, BY GEOGRAPHY ($MILLION)
187 STRYKER REVENUES AND R&D EXPENSES ($MILLION)
188 STRYKER REVENUES, BY SEGMENTS ($MILLION)
189 STRYKER REVENUES, BY GEOGRAPHY ($MILLION)
190 SYNTHES REVENUES AND R&D EXPENSES ($MILLION)
191 SYNTHES REVENUES, BY GEOGRAPHY ($MILLION)
192 WRIGHT MEDICAL REVENUES AND R&D EXPENSES ($MILLION)
193 WRIGHT MEDICAL REVENUES, BY SEGMENTS ($MILLION)
194 WRIGHT MEDICAL REVENUES, BY GEOGRAPHY ($MILLION)
195 ZIMMER REVENUES AND R&D EXPENSES ($MILLION)
196 ZIMMER REVENUES, BY GEOGRAPHY ($MILLION)
197 ZIMMER REVENUES, BY SEGMENTS ($MILLION)
 

LIST OF FIGURES
 
1 GLOBAL BIOMATERIAL MARKET
2 EVOLUTION OF BIOMATERIAL MARKET
3 PARENTAL STRUCTURE OF BIOMATERIAL MARKET
4 CHARACTERISTICS OF BIOMATERIAL SCIENCE
5 BIOMATERIAL MARKET: SEGMENTATION
6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)
7 INCREASING DISABILITY WITH AGE
8 INCREASING AGING POPULATION
9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2010)
10 FACTORS AFFECTING THE BIOMATERIAL MARKET
11 BIOMATERIAL PATENTS, BY GEOGRAPHY

Global Biomaterials Market (2010-2015)

“Biomaterials” is a combination of four major sciences; namely basic science, medical science, engineering science, and forensic science. It is the physical, chemical, and biological study of materials and their interaction with the biological environment. Various materials such as metals, polymers, ceramics, and composites are formulated in medical devices and then used to restore damaged tissues in the human body. With the emergence of biotechnology, the application areas of biomaterials have also increased and “biomaterials” is now playing an important part in the medical sector. Surgical appliances and supplies, surgical and medical instruments, drug delivery, general surgery, electromedical, dental products are amongst the application areas of biomaterials.

CHARACTERISTICS OF BIOMATERIAL SCIENCE

Source: MarketsandMarkets Analysis